The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis
Identifieur interne : 000579 ( Pmc/Corpus ); précédent : 000578; suivant : 000580The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis
Auteurs : A. Badawi ; S. RyooSource :
- International Journal of Infectious Diseases [ 1201-9712 ] ; 2016.
Url:
DOI: 10.1016/j.ijid.2016.02.392
PubMed: NONE
PubMed Central: 7128436
Links to Exploration step
PMC:7128436Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis</title>
<author><name sortKey="Badawi, A" sort="Badawi, A" uniqKey="Badawi A" first="A." last="Badawi">A. Badawi</name>
<affiliation><nlm:aff id="aff0005">Public Health Agency of Canada, Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ryoo, S" sort="Ryoo, S" uniqKey="Ryoo S" first="S." last="Ryoo">S. Ryoo</name>
<affiliation><nlm:aff id="aff0010">University of Toronto, Toronto, Canada</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7128436</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128436</idno>
<idno type="RBID">PMC:7128436</idno>
<idno type="doi">10.1016/j.ijid.2016.02.392</idno>
<idno type="pmid">NONE</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">000579</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000579</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis</title>
<author><name sortKey="Badawi, A" sort="Badawi, A" uniqKey="Badawi A" first="A." last="Badawi">A. Badawi</name>
<affiliation><nlm:aff id="aff0005">Public Health Agency of Canada, Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ryoo, S" sort="Ryoo, S" uniqKey="Ryoo S" first="S." last="Ryoo">S. Ryoo</name>
<affiliation><nlm:aff id="aff0010">University of Toronto, Toronto, Canada</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">International Journal of Infectious Diseases</title>
<idno type="ISSN">1201-9712</idno>
<idno type="eISSN">1878-3511</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pmc article-type="abstract"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Infect Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Int. J. Infect. Dis</journal-id>
<journal-title-group><journal-title>International Journal of Infectious Diseases</journal-title>
</journal-title-group>
<issn pub-type="ppub">1201-9712</issn>
<issn pub-type="epub">1878-3511</issn>
<publisher><publisher-name>Published by Elsevier Ltd.</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmc">7128436</article-id>
<article-id pub-id-type="publisher-id">S1201-9712(16)30371-X</article-id>
<article-id pub-id-type="doi">10.1016/j.ijid.2016.02.392</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Badawi</surname>
<given-names>A.</given-names>
</name>
<xref rid="aff0005" ref-type="aff">1</xref>
<xref rid="cor0005" ref-type="corresp">⁎</xref>
</contrib>
<contrib contrib-type="author" id="aut0010"><name><surname>Ryoo</surname>
<given-names>S.</given-names>
</name>
<xref rid="aff0010" ref-type="aff">2</xref>
</contrib>
</contrib-group>
<aff id="aff0005"><label>1</label>
Public Health Agency of Canada, Toronto, Canada</aff>
<aff id="aff0010"><label>2</label>
University of Toronto, Toronto, Canada</aff>
<author-notes><corresp id="cor0005"><label>⁎</label>
Corresponding author.</corresp>
</author-notes>
<pub-date pub-type="pmc-release"><day>29</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub"><month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>29</day>
<month>3</month>
<year>2016</year>
</pub-date>
<volume>45</volume>
<fpage>165</fpage>
<lpage>165</lpage>
<permissions><copyright-statement>Copyright © 2016 Published by Elsevier Ltd.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder></copyright-holder>
<license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
</license>
</permissions>
</article-meta>
</front>
<body><p id="par0005"><bold>Background</bold>
: A number of acute respiratory infections outbreaks such as the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV) have emerged and presented a considerable global public health threat. Epidemiologic evidence suggest that diabetic subjects are more susceptible to these conditions. However, the global influence of diabetes to the severity of H1N1 and MERS-CoV is yet to be evaluated.</p>
<p id="par0010"><bold>Objective:</bold>
The aim of this study was to carry out a systematic review and meta-analysis documenting the prevalence of diabetes in sever H1N1 and MERS-CoV to enable estimating its contribution to the severity of these conditions.</p>
<p id="par0015"><bold>Methods & Materials</bold>
: A search strategy was developed for online databases (PubMed, Ovid MEDLINE, Embase and Embase Classic) using H1N1, MERS-CoV and DIABETES as search terms. Reports documenting the prevalence of diabetes in these conditions were identified. Meta-analysis for the proportions of diabetes in sever conditions (95% confidence intervals, CI) was carried out (29 H1N1 studies, <italic>n</italic>
=92,948 subjects and 9 MERS-CoV studies, <italic>n</italic>
=308). Weighted averages of the extracted information and subgroup analysis (by region) were carried out.</p>
<p id="par0020"><bold>Results</bold>
: Average age of H1N1 patients (38.0 ± 9.2 yrs) was lower than that MERS-CoV patients (54.9 ± 10.1 yrs, p<0.05). The prevalence rates of clinical symptoms such as pyrexia, dyspnea, pharyngitis and pertussis were comparable between the two conditions. Compared to MERS-CoV patients, H1N1 subjects exhibited 3-fold lower prevalence of cardiovascular diseases and 2- and 4-fold higher obesity and immunosuppression rates, respectively. The prevalence of diabetes in sever H1N1 was 14.6% (95%CI: 12.3-17.0%; p<0.001), a 3.7-fold lower than in MERS-CoV (54.4%; 95%CI: 29.4-79.5; p<0.001). The contribution of diabetes to the severity of H1N1 from Asia (18%) and North America (20%) was 2-fold higher than that from South America (9.8%) and Europe (10%).</p>
<p id="par0025"><bold>Conclusion</bold>
: The effect of diabetes is 4-fold higher in MERS-CoV than in H1N1 and may play a significant role in the susceptibly to these conditions and vulnerability to their ensuing sever complications. The high prevalence of diabetes in H1N1 in North America and Asia may reflect its elevated prevalence in these regions.</p>
</body>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000579 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000579 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:7128436 |texte= The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |